Jason J Wang1, Artem Boltyenkov2, Jeffrey M Katz3, Joseph O'Hara4, Michele Gribko5, Pina C Sanelli6. 1. Imaging Clinical Effectiveness and Outcomes Research, Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, New York; Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York. 2. Imaging Clinical Effectiveness and Outcomes Research, Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, New York; Siemens Medical Solutions USA, Malvern, Pennsylvania. 3. Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York; Department of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York. 4. Imaging Clinical Effectiveness and Outcomes Research, Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, New York. 5. Department of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York. 6. Imaging Clinical Effectiveness and Outcomes Research, Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, New York; Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York; Vice-Chair, Research, Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York. Electronic address: psanelli@northwell.edu.
Abstract
PURPOSE: Prior studies have shown socioeconomic disparities in advanced neuroimaging and acute treatment utilization in patients with ischemic stroke. The authors analyzed whether socioeconomic factors were associated with stroke neuroimaging and acute treatment utilization at a comprehensive stroke center. METHODS: A retrospective study of consecutive acute ischemic stroke discharges from 2012 to 2020 at a comprehensive stroke center was performed. Differences in neuroimaging (CT angiography [CTA], CT perfusion, MRI, and MR angiography [MRA]) and acute treatment (intravenous thrombolysis [IVT] and endovascular thrombectomy [EVT]) utilization were evaluated on the basis of socioeconomic factors of age, sex, race, insurance type, and neighborhood-level median household income. Chi-square tests were used for bivariate analyses. Multivariable logistic regression analyses were performed to determine associations between socioeconomic factors and neuroimaging or treatment utilization while controlling for stroke-specific factors and comorbidities. RESULTS: Among 6,140 ischemic stroke discharges, race and insurance type were not significantly associated with lower utilization of neuroimaging (CTA, CT perfusion, MRI, and MRA) or acute stroke treatment (IVT and EVT) after controlling for stroke-specific factors and comorbidities. However, median household income < $80,000/year was associated with lower IVT use (odds ratio [OR], 0.74; 95% confidence interval [CI], 0.63-0.87). In addition, age ≥ 80 years had lower CTA (OR, 0.62; 95% CI, 0.51-0.75) and EVT (OR, 0.53; 95% CI, 0.39-0.73) utilization, and female sex had lower CTA (OR, 0.78; 95% CI, 0.65-0.93) utilization. Significantly higher utilization was observed for MRI in Asian (OR, 1.33; 95% CI, 1.04-1.69) and uninsured (OR, 1.64; 95% CI, 1.07-2.50) patients and for MRA (OR, 1.24; 95% CI, 1.04-1.49) and EVT (OR, 1.62; 95% CI, 1.20-2.20) in privately insured patients. CONCLUSIONS: Once access to a comprehensive stroke center is achieved, socioeconomic disparities in the utilization of health care resources, particularly advanced neuroimaging and acute treatment, may be improved in patients with ischemic stroke.
PURPOSE: Prior studies have shown socioeconomic disparities in advanced neuroimaging and acute treatment utilization in patients with ischemic stroke. The authors analyzed whether socioeconomic factors were associated with stroke neuroimaging and acute treatment utilization at a comprehensive stroke center. METHODS: A retrospective study of consecutive acute ischemic stroke discharges from 2012 to 2020 at a comprehensive stroke center was performed. Differences in neuroimaging (CT angiography [CTA], CT perfusion, MRI, and MR angiography [MRA]) and acute treatment (intravenous thrombolysis [IVT] and endovascular thrombectomy [EVT]) utilization were evaluated on the basis of socioeconomic factors of age, sex, race, insurance type, and neighborhood-level median household income. Chi-square tests were used for bivariate analyses. Multivariable logistic regression analyses were performed to determine associations between socioeconomic factors and neuroimaging or treatment utilization while controlling for stroke-specific factors and comorbidities. RESULTS: Among 6,140 ischemic stroke discharges, race and insurance type were not significantly associated with lower utilization of neuroimaging (CTA, CT perfusion, MRI, and MRA) or acute stroke treatment (IVT and EVT) after controlling for stroke-specific factors and comorbidities. However, median household income < $80,000/year was associated with lower IVT use (odds ratio [OR], 0.74; 95% confidence interval [CI], 0.63-0.87). In addition, age ≥ 80 years had lower CTA (OR, 0.62; 95% CI, 0.51-0.75) and EVT (OR, 0.53; 95% CI, 0.39-0.73) utilization, and female sex had lower CTA (OR, 0.78; 95% CI, 0.65-0.93) utilization. Significantly higher utilization was observed for MRI in Asian (OR, 1.33; 95% CI, 1.04-1.69) and uninsured (OR, 1.64; 95% CI, 1.07-2.50) patients and for MRA (OR, 1.24; 95% CI, 1.04-1.49) and EVT (OR, 1.62; 95% CI, 1.20-2.20) in privately insured patients. CONCLUSIONS: Once access to a comprehensive stroke center is achieved, socioeconomic disparities in the utilization of health care resources, particularly advanced neuroimaging and acute treatment, may be improved in patients with ischemic stroke.
Authors: Lorenzo Rinaldo; Alejandro A Rabinstein; Harry Cloft; John M Knudsen; Leonardo Rangel Castilla; Waleed Brinjikji Journal: Stroke Date: 2019-08-01 Impact factor: 7.914
Authors: Callum M Dupre; Richard Libman; Samuel I Dupre; Jeffrey M Katz; Igor Rybinnik; Thomas Kwiatkowski Journal: J Stroke Cerebrovasc Dis Date: 2013-08-15 Impact factor: 2.136
Authors: M Elizabeth Sandel; Hua Wang; Joseph Terdiman; Jeanne M Hoffman; Marcia A Ciol; Steven Sidney; Charles Quesenberry; Qi Lu; Leighton Chan Journal: PM R Date: 2009-01-09 Impact factor: 2.298
Authors: Waleed Brinjikji; Abdulrahman M El-Sayed; Alejandro A Rabinstein; Jennifer S McDonald; Harry J Cloft Journal: AJR Am J Roentgenol Date: 2014-08 Impact factor: 3.959
Authors: Juliet Addo; Luis Ayerbe; Keerthi M Mohan; Siobhan Crichton; Anita Sheldenkar; Ruoling Chen; Charles D A Wolfe; Christopher McKevitt Journal: Stroke Date: 2012-02-23 Impact factor: 7.914